Between 2013 and 2023, insulin dosage market value per capita in New Zealand showed a steady increase with fluctuations. As of 2023, the value reached 16.5 USD per capita. Notably, from 2021 to 2022, there was a 7.26% increase, followed by a further 5.36% rise from 2022 to 2023. Over the past five years, the Compound Annual Growth Rate (CAGR) averaged at approximately 2.60%.
Future trends to watch include:
- Technological advances in insulin delivery systems.
- New product launches and innovations in diabetes management.
- Potential impacts of healthcare policy changes and insurance coverage adjustments.
- Increased demand driven by rising diabetes prevalence.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 9 | 9 Sweden | 19.49 | 2023 | View data | ||
| 10 | 10 Spain | 18.61 | 2023 | View data | ||
| 11 | 11 New Zealand | 16.5 | 2023 | |||
| 12 | 12 Slovenia | 16.43 | 2023 | View data | ||
| 13 | 13 Slovakia | 13.6 | 2023 | View data | ||
